to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction

NCT05162261 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Meibomian Gland Dysfunction
Dry Eye Syndromes
Dry Eye

Interventions

DEVICE: Tixel C
DEVICE: LipiFlow

Sponsor

Novoxel Ltd.